Journal of Interventional and General Cardiology

Institute of Clinical Medicine, University of Oslo, Oslo, Norway

Publications

• Mini Review   
  Cardioversion Safety– Is It Safe To Say That We Are Doing Enough?
  Author(s): Mohsen Khatami*, MaritaKnudsen Pope, Sophie Le Page, Petra Radic, Valentina Schirripa, Irene Grundvold and Dan Atar
  
  There is a significant periprocedural hazard of thromboembolic occasions in atrial fibrillation patients going through cardio-variant, and treatment with anticoagulants is accordingly a sign of cardioversion well being. In view of review sub-bunch examinations and imminent investigations, non-nutrient K enemies of coagulants are in any event as proficient as nutrient K-foes in forestalling thromboembolic intricacies after cardiovariant. The danger of thromboembolic intricacies after vehicle dioversion particularly relies upon the comorbidities in a given patient, and particularly cardiovascular breakdown, diabetes, and age. >75 years convey a uniquely expanded danger. Cardioversion has been viewed as protected inside a 48-h time window after beginning of atrial fibrillation without earlier treatment with anticoagulants, however late investigations have set this training into questi.. Read More»
  DOI: 10.37421/2684-4591.21.5.127

  Abstract HTML PDF